ŌURA, developer of smart ring health monitoring technology, has completed a $200 million Series D funding round, elevating its valuation to $5.2 billion. The investment, led by Fidelity Management & Research Company with participation from Dexcom, positions the company for its next phase of growth in digital health monitoring.
The new funding will enable ŌURA to enhance its product offerings and expand research initiatives while accelerating its global market presence. The company plans to allocate resources toward developing new features, advancing its technology platform, and pursuing strategic acquisitions to complement its existing capabilities.
Since its establishment in 2013, ŌURA has evolved from a sleep tracking device manufacturer to a comprehensive health monitoring platform. The company's latest innovation, the Oura Ring 4, incorporates Smart Sensing technology to provide precise health metrics across multiple domains, including sleep patterns, cardiovascular health, stress indicators, and women's health parameters.
The funding announcement comes amid substantial growth metrics for the company. ŌURA reports sales exceeding 2.5 million rings, alongside doubled membership and revenue figures over the past year. The company has strengthened its market presence through retail partnerships with Amazon and Target, while establishing commercial relationships within military sectors.
ŌURA's health monitoring ecosystem now encompasses more than 800 partnerships across various health sectors. The platform serves multiple stakeholders, including research institutions, healthcare providers, and organizational teams focused on health outcome improvement.
CEO Tom Hale emphasized the company's focus on artificial intelligence development as a central component of their growth strategy. The additional funding will support ŌURA's mission to integrate health monitoring into daily practices, with plans to explore opportunities beyond their current ring-based technology platform.
Click here for the original news story.